The Development of FAK Inhibitors: A Five-Year Update

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase over-expressed in different solid cancers. In recent years, FAK has been recognized as a new target for the development of antitumor agents, useful to contrast tumor development and metastasis formation. To date, studies on the role of FA...

Descripción completa

Detalles Bibliográficos
Autores principales: Spallarossa, Andrea, Tasso, Bruno, Russo, Eleonora, Villa, Carla, Brullo, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223874/
https://www.ncbi.nlm.nih.gov/pubmed/35742823
http://dx.doi.org/10.3390/ijms23126381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223874/
https://www.ncbi.nlm.nih.gov/pubmed/35742823
http://dx.doi.org/10.3390/ijms23126381

Ejemplares similares